Toroso Investments LLC Increases Stock Holdings in AmerisourceBergen Co. (NYSE:ABC)

Toroso Investments LLC boosted its stake in AmerisourceBergen Co. (NYSE:ABC – Get Rating) by 13.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,374 shares of the company’s stock after buying an additional 893 shares during the quarter. Toroso Investments LLC’s holdings in AmerisourceBergen were worth $998,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of AmerisourceBergen by 7.4% in the first quarter. Vanguard Group Inc. now owns 18,411,527 shares of the company’s stock valued at $2,848,446,000 after purchasing an additional 1,269,147 shares during the last quarter. Invesco Ltd. increased its stake in AmerisourceBergen by 42.3% in the 1st quarter. Invesco Ltd. now owns 2,079,491 shares of the company’s stock valued at $321,717,000 after buying an additional 618,248 shares during the last quarter. Amundi lifted its position in shares of AmerisourceBergen by 83.9% during the 2nd quarter. Amundi now owns 1,283,724 shares of the company’s stock worth $179,118,000 after buying an additional 585,778 shares in the last quarter. FMR LLC boosted its stake in shares of AmerisourceBergen by 10.2% in the 2nd quarter. FMR LLC now owns 5,664,668 shares of the company’s stock worth $801,436,000 after buying an additional 523,003 shares during the last quarter. Finally, Boston Partners grew its holdings in shares of AmerisourceBergen by 11.4% in the third quarter. Boston Partners now owns 5,041,639 shares of the company’s stock valued at $684,631,000 after acquiring an additional 514,462 shares in the last quarter. 84.79% of the stock is currently owned by institutional investors.

AmerisourceBergen Trading Down 0.0 %

NYSE:ABC opened at $152.02 on Friday. AmerisourceBergen Co. has a 1 year low of $135.14 and a 1 year high of $174.63. The stock’s fifty day moving average price is $158.84 and its two-hundred day moving average price is $156.06. The company has a debt-to-equity ratio of 63.30, a current ratio of 0.91 and a quick ratio of 0.53. The company has a market cap of $30.75 billion, a P/E ratio of 18.45, a P/E/G ratio of 1.47 and a beta of 0.54.

AmerisourceBergen (NYSE:ABC – Get Rating) last issued its quarterly earnings data on Wednesday, February 1st. The company reported $2.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.62 by $0.09. AmerisourceBergen had a return on equity of 597.57% and a net margin of 0.72%. The business had revenue of $62.85 billion for the quarter, compared to analysts’ expectations of $62.77 billion. During the same quarter in the prior year, the firm posted $2.58 EPS. The firm’s quarterly revenue was up 5.4% on a year-over-year basis. As a group, analysts expect that AmerisourceBergen Co. will post 11.61 EPS for the current year.

AmerisourceBergen Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 27th. Stockholders of record on Friday, February 10th were given a $0.485 dividend. The ex-dividend date of this dividend was Thursday, February 9th. This represents a $1.94 dividend on an annualized basis and a dividend yield of 1.28%. AmerisourceBergen’s dividend payout ratio (DPR) is currently 23.54%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ABC. TheStreet cut AmerisourceBergen from a “b-” rating to a “c” rating in a research report on Monday, March 6th. StockNews.com initiated coverage on shares of AmerisourceBergen in a report on Thursday. They set a “strong-buy” rating for the company. UBS Group increased their target price on shares of AmerisourceBergen from $184.00 to $190.00 and gave the company a “buy” rating in a research report on Tuesday, January 31st. Mizuho raised their price target on shares of AmerisourceBergen from $162.00 to $170.00 and gave the stock a “neutral” rating in a research note on Thursday, February 2nd. Finally, Argus upped their price objective on AmerisourceBergen from $170.00 to $190.00 and gave the company a “buy” rating in a research note on Thursday, January 12th. Two investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $180.08.

Insider Buying and Selling

In other AmerisourceBergen news, CEO Steven H. Collis sold 10,499 shares of the stock in a transaction that occurred on Tuesday, March 14th. The shares were sold at an average price of $150.00, for a total value of $1,574,850.00. Following the sale, the chief executive officer now directly owns 257,967 shares in the company, valued at approximately $38,695,050. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Gina Clark sold 1,924 shares of the business’s stock in a transaction dated Wednesday, March 1st. The stock was sold at an average price of $156.22, for a total transaction of $300,567.28. Following the completion of the transaction, the executive vice president now directly owns 26,733 shares in the company, valued at $4,176,229.26. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Steven H. Collis sold 10,499 shares of the firm’s stock in a transaction dated Tuesday, March 14th. The shares were sold at an average price of $150.00, for a total value of $1,574,850.00. Following the completion of the sale, the chief executive officer now directly owns 257,967 shares in the company, valued at approximately $38,695,050. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 30,851 shares of company stock valued at $4,865,455. Company insiders own 20.10% of the company’s stock.

AmerisourceBergen Profile

(Get Rating)

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies.